Skip to content
MARKETS / NASDAQ / KIDS
NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · MID CAP

Orthopediatrics Corp. KIDS

11 fiscal years on record · USD · FY2025 reported · SEC filings only
$236.3M
▲ 15.4% YoY
$-39.6M
$-16.0M
In brief

What this company does

OrthoPediatrics Corp. designs, develops and markets anatomically appropriate implants, instruments and specialized braces for children with orthopedic conditions. It sells its specialized products, including PediLoc, PediPlates, the ApiFix Mid-C System and Boston Brace 3D bracing products, to hospitals and medical facilities throughout the United States and various international markets, using a contract manufacturing model for implants and related surgical instrumentation while manufacturing its orthopedic bracing products in-house. The company also operates multiple orthotic and prosthetic clinics that deliver pediatric non-surgical O&P treatment. As of December 31, 2025, the company and its subsidiaries had 602 full-time equivalent employees. It sells its products in over 75 countries outside of the United States. For the years ended December 31, 2025, 2024 and 2023, its revenue was $236.3 million, $204.7 million and $148.7 million, respectively. OrthoPediatrics Corp. was initially organized as an Indiana limited liability company on August 31, 2006, and was converted to a Delaware corporation on November 30, 2007.

Written from the business description in ORTHOPEDIATRICS CORP's annual report to the U.S. Securities and Exchange Commission, filed 4 March 2026. Every sentence was checked against that document before publication.

Growth
USD 236.3M
Revenue, FY2025 · full 11-year series below
Revenue $M Net income $M
FY2025 · Revenue 236.3 · Net income -39.6
80M160M-20M201520172019202120232025
Compound annual growth
+24.6%
+27.2%
+22.5%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +27.2% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−17 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -16.6% · Net -16.8%
-20%-40%201520172019202120232025
ROE
FY2025 · ROE -11.3%
-5%-10%-15%201520172019202120232025

Each USD of equity lost 11 cents this year.

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -16.0
-20M-40M201520172019202120232025
Net buybacks $M Dividends $M
FY2019 · Dividends 0.0 · Net buybacks —
2M4M20152016201720182019

Total assetsUSD 508.6M
EquityUSD 346.6M
CashUSD 19.6M
Gross debtUSD 101.7M
Net debtUSD 82.1M
Current ratio5.55×

Net debt stands at 24% of equity.

The 11-year record
11 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 20252024202320222021202020192018201720162015
Revenue $B0.20.20.10.10.10.10.10.10.00.00.0
Operating income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EBITDA $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
Income tax $B0.0−0.0−0.0−0.0−0.0−0.00.00.00.00.00.0
Net income $B−0.0−0.0−0.00.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
Free cash flow $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EPS, diluted $−1.69−1.64−0.920.06−0.84−1.82−0.94−0.96−5.86−7.14−7.27
Dividend / sh $···········
Payout %······−0−0−67−0−0
ROE %−11.3−10.3−5.60.4−7.1−17.5−12.3−18.6···
Shares out B0.030.020.020.020.020.020.020.010.010.00·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 53 reconciliationsAUDITED

Reconciled in 11 of 19 fiscal years. 42 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivitySurgical & Medical Instruments & Apparatus
Listed onNASDAQ
Incorporated innot stated in the filings
Fiscal year endsDecember 31
Data on record since2015

Share this section

Download image